Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Stockholders' Equity

v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Common Stock and Capital in Excess of Par
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Non-Controlling Interests
Beginning Balance, shares at Dec. 31, 2022     4,137        
Beginning Balance at Dec. 31, 2022 $ 103,286   $ 31,580 $ (562) $ 70,405   $ 1,863
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 1,675       1,689   (14)
Other comprehensive income (loss) 347     347      
Net proceeds from sales of subsidiary shares and partner contributions 4,005   $ 1,620       2,385
Employee equity incentive plans and other, shares     107        
Employee equity incentive plans and other 1,044   $ 1,044        
Share-based compensation 3,229   $ 3,088       141
Restricted stock unit withholdings, shares     (16)        
Restricted stock unit withholdings (533)   $ (683)   150    
Cash dividends declared (3,088)       (3,088)    
Ending Balance, shares at Dec. 30, 2023     4,228        
Ending Balance at Dec. 30, 2023 109,965   $ 36,649 (215) 69,156   4,375
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (19,233)       (18,756)   (477)
Other comprehensive income (loss) (496)     (496)      
Net proceeds from sales of subsidiary shares and partner contributions 12,714   $ 11,012       1,702
Partner distributions (43)           (43)
Employee equity incentive plans and other, shares     123        
Employee equity incentive plans and other 988   $ 988        
Share-based compensation 3,367   $ 3,162       205
Restricted stock unit withholdings, shares     (21)        
Restricted stock unit withholdings (631)   $ (862)   231    
Cash dividends declared $ (1,599)       (1,599)    
Ending Balance, shares at Dec. 28, 2024 4,330   4,330        
Ending Balance at Dec. 28, 2024 $ 105,032 $ 49 $ 50,949 (711) 49,032 [1] $ 49 5,762
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 26       (267)   293
Other comprehensive income (loss) 824     824      
Net proceeds from stock issuances and warrants (in shares) [2]     580        
Net proceeds from stock issuances and warrants [2] 11,835   $ 11,835        
Net proceeds from sales of subsidiary shares and partner contributions 6,029   $ 59       5,970
Partner distributions (217)           (217)
Employee equity incentive plans and other, shares     101        
Employee equity incentive plans and other 771   $ 771        
Share-based compensation 2,434   $ 2,163       271
Restricted stock unit withholdings, shares     (17)        
Restricted stock unit withholdings $ (423)   $ (592)   169    
Ending Balance, shares at Dec. 27, 2025 4,994   4,994        
Ending Balance at Dec. 27, 2025 $ 126,360   $ 65,185 $ 113 $ 48,983   $ 12,079
[1] We made a cumulative-effect adjustment to the opening balance of retained earnings upon adopting ASU 2023-08 in 2025.
[2] Includes $110 million of allocated proceeds to warrants from the U.S. Government Agreement we entered into in August 2025.
See accompanying notes.